Gottlieb blasts high insulin prices, touts far-off new rules he says will spur competition in that market
(By Nicholas Florko for STAT) WASHINGTON — FDA Commissioner Scott Gottlieb blasted insulin makers Tuesday for what he called unacceptably
Read More